Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy

NCT: NCT05370612 · COMPLETED

NCT IDNCT05370612
StatusCOMPLETED
Start Date2022-08-08
Completion2024-10-06

Brief Summary

This study will assess differences in patient preferences and glucose control between continuous glucose monitoring and standard glucose checks in pregnant patients with Type 2 Diabetes. 40 participants will be on study for approximately 182 days (26 weeks).

Frequently Asked Questions

What is AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy?

AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy is a clinical trial registered under NCT05370612. Current status: COMPLETED.

What is the status of NCT05370612?

The current status of NCT05370612 (AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy) is: COMPLETED.

When did AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy start?

AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy started on 2022-08-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑